Adaptimmune Therapeutics (ADAPY) Shares Outstanding (Diluted) (2015 - 2025)
Adaptimmune Therapeutics (ADAPY) posted Shares Outstanding (Diluted) of 1.58 billion for Q2 2025, up 1.6% from 1.56 billion a year earlier and up 2.7% from the prior quarter.
Powered by 
Analysis
Adaptimmune Therapeutics (ADAPY) Shares Outstanding (Diluted) (2015 - 2025) Analysis & Trends
For FY2024, Adaptimmune Therapeutics' Shares Outstanding (Diluted) came in at 1.51 billion, up 25.5% from FY2023.
- Annual Shares Outstanding (Diluted) has increased for seven consecutive years, with a five-year compound annual growth rate of 19.2% (FY2019 to FY2024).
- In prior years, Adaptimmune Therapeutics' Shares Outstanding (Diluted) was 1.21 billion in FY2023 (+24.7%), 967.24 million in FY2022 (+3.5%), 934.83 million in FY2021 (+9.4%) and 854.78 million in FY2020 (+35.7%).
- The Q2 2025 figure stands as the highest quarterly Shares Outstanding (Diluted) in data going back to Q3 2017.
- On a year-over-year basis, Shares Outstanding (Diluted) has increased in each of the last 19 quarters, with growth averaging 24.4% over the last eight quarters.
- The strongest year-over-year quarter for Shares Outstanding (Diluted) in the past five years was Q3 2021, with growth of 48.7%; the weakest was Q3 2020, with a decline of 0.2%.
- According to Business Quant data, Shares Outstanding (Diluted) for the three prior quarters was 1.54 billion (Q1 2025), 1.51 billion (Q4 2024) and 1.53 billion (Q3 2024).
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2025 | 198.07 Mn |
| Mar 31, 2025 | 192.77 Mn |
| Dec 31, 2024 | 189.23 Mn |
| Sep 30, 2024 | 191.83 Mn |
| Jun 30, 2024 | 194.90 Mn |
| Mar 31, 2024 | 181.41 Mn |
| Dec 31, 2023 | 150.81 Mn |
| Sep 30, 2023 | 169.73 Mn |
| Jun 30, 2023 | 138.52 Mn |
| Mar 31, 2023 | 125.03 Mn |
| Dec 31, 2022 | 120.91 Mn |
| Sep 30, 2022 | 122.60 Mn |
| Jun 30, 2022 | 120.35 Mn |
| Mar 31, 2022 | 117.50 Mn |
| Dec 31, 2021 | 116.85 Mn |
| Sep 30, 2021 | 117.08 Mn |
| Jun 30, 2021 | 116.78 Mn |
| Mar 31, 2021 | 116.39 Mn |
| Dec 31, 2020 | 106.85 Mn |
| Sep 30, 2020 | 116.00 Mn |
API Access
Adaptimmune Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ADAPY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "ADAPY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=ADAPY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();